Compare Elevance Health Inc. Common Stock (ELV) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elevance Health Inc. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Elevance Health Inc. Common Stock trades at $415.24 (market cap $86.95B), while Halozyme Therapeutics Inc. Common Stock trades at $112.19 (market cap $12.58B). The key difference: Elevance Health Inc. Common Stock is far larger — about 6.9× Halozyme Therapeutics Inc. Common Stock's market cap, and Elevance Health Inc. Common Stock pays a 1.72% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ELV | HALO | |
|---|---|---|
Market Cap | $86.95B | $12.58B |
Volume | 782,706 | 2,179,278 |
Sector | Health | Health |
52-Week High | $426.79 | $115.22 |
52-Week Low | $280.74 | $61.63 |
Enterprise Value | $107.76B | $14.49B |
Dividend Yield | 1.72% | — |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Elevance Health Inc. Common Stock
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
